TABLE 2.
Strain | Country (area)a | PFGE subtype | Resistance gene | MLST type | Allele at:
|
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
atpA | ddl | gdh | purK | gyd | pstS | adk | |||||
AE1 | IT (C) | 1.1 | vanA | ST78 | 15 | 1 | 1 | 1 | 1 | 1 | 1 |
AE20b | IT (S) | 1.1 | vanA | ST78 | 15 | 1 | 1 | 1 | 1 | 1 | 1 |
AE10 | IT (N) | 1.7 | vanA | ST78 | 15 | 1 | 1 | 1 | 1 | 1 | 1 |
AE15 | IT (N) | 1.10 | vanA | ST78 | 15 | 1 | 1 | 1 | 1 | 1 | 1 |
AE12 | IT (N) | 2.0 | vanB | ST209 | 37 | 1 | 1 | 1 | 1 | 1 | 1 |
A0007 | UK | vanA | ST17 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
R05 | AU | vanB | ST17 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
A0008c | AU | ST17 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
IT, Italy; UK, United Kingdom; AU, Australia; C, central; S, southern; N, northern.
Resistant to quinupristin-dalfopristin.
Susceptible to vancomycin.